These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16574706)

  • 21. [Alcoholic intoxication in children and adolescents].
    Schmitz G
    Kinderkrankenschwester; 2012 Nov; 31(11):447-9. PubMed ID: 23256411
    [No Abstract]   [Full Text] [Related]  

  • 22. Alcohol, ecstasy, Aldous Huxley's 'soma'.
    Parrott AC
    J Psychopharmacol; 2007 Jan; 21(1):8-9. PubMed ID: 17213249
    [No Abstract]   [Full Text] [Related]  

  • 23. [The issue of harm reduction in Polish legislation concerning drug addiction. A comparative study].
    Sobeyko J
    Ann Acad Med Stetin; 2008; 54(2):119-31. PubMed ID: 19374242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How the harm reduction movement contrasts itself against punitive prohibition.
    Tammi T; Hurme T
    Int J Drug Policy; 2007 Mar; 18(2):84-7. PubMed ID: 17689349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Craxi and drugs].
    Cugurra F
    Clin Ter; 1989 Mar; 128(6):379-85. PubMed ID: 2524324
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug policing, harm reduction and health: directions for advocacy.
    Burris S; Burrows D
    Int J Drug Policy; 2009 Jul; 20(4):293-5. PubMed ID: 19403297
    [No Abstract]   [Full Text] [Related]  

  • 27. The detection of illicit drugs in oral fluid: another potential strategy to reduce illicit drug-related harm.
    Dyer KR; Wilkinson C
    Drug Alcohol Rev; 2008 Jan; 27(1):99-107. PubMed ID: 18034388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tobacco and alcohol should be classed as dangerous drugs.
    O'Dowd A
    BMJ; 2006 Aug; 333(7562):275. PubMed ID: 16888297
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug prohibition and the treatment system: perfect together.
    Magura S
    Subst Use Misuse; 2007; 42(2-3):495-501. PubMed ID: 17558947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strengthening drug policy and practice through ethics engagement: an old challenge for a new harm reduction.
    Irwin KS; Fry CL
    Int J Drug Policy; 2007 Mar; 18(2):75-83. PubMed ID: 17689348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The size and mix of government spending on illicit drug policy in Australia.
    Moore TJ
    Drug Alcohol Rev; 2008 Jul; 27(4):404-13. PubMed ID: 18584391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Basing drug scheduling decisions on scientific ranking of harmfulness: false promise from false premises.
    Caulkins JP; Reuter P; Coulson C
    Addiction; 2011 Nov; 106(11):1886-90. PubMed ID: 21895823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is kava alcohol?: The myths and the facts.
    Aporosa SA
    Pac Health Dialog; 2011 Mar; 17(1):157-64. PubMed ID: 23008981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coke and smack at the drugstore: harm reductive drug legalization: an alternative to a criminalization society.
    Mamber N
    Cornell J Law Public Policy; 2006; 15(3):619-64. PubMed ID: 17593583
    [No Abstract]   [Full Text] [Related]  

  • 35. Keeping them connected--reducing drug-related harm in Australian schools from a Catholic perspective.
    Norden P
    Drug Alcohol Rev; 2008 Jul; 27(4):451-8. PubMed ID: 18584402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. International control of alcohol: alternative paths forward.
    Room R
    Drug Alcohol Rev; 2006 Nov; 25(6):581-95. PubMed ID: 17132575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding post 9/11 drug control policy and politics in Central Asia.
    Latypov A
    Int J Drug Policy; 2009 Sep; 20(5):387-91. PubMed ID: 19121928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychopharmacology of alcohol. II. Affective tolerance in alcohol intoxication.
    Mayfield DG
    J Nerv Ment Dis; 1968 Apr; 146(4):322-7. PubMed ID: 5652841
    [No Abstract]   [Full Text] [Related]  

  • 39. Assessing abuse liability during drug development: changing standards and expectations.
    Schoedel KA; Sellers EM
    Clin Pharmacol Ther; 2008 Apr; 83(4):622-6. PubMed ID: 18212799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The combined effect of alcohol and psychopharmacological drugs. A review of cases submitted to the Medico-Legal Council in a 15-year period].
    Reisby N
    Ugeskr Laeger; 1967 Jan; 129(4):109-17. PubMed ID: 5599678
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.